18 min listen
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
FromThe Uromigos
ratings:
Length:
30 minutes
Released:
Feb 11, 2020
Format:
Podcast episode
Description
Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.
Released:
Feb 11, 2020
Format:
Podcast episode
Titles in the series (100)
Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg by The Uromigos